Back to News
Market Impact: 0.18
Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know
Source: zacks.com
Analyst EstimatesAnalyst InsightsHealthcare & Biotech
Analysts' average price target for Progyny implies 25.2% upside. While the article cautions that price-target averages have limited predictive value, broad analyst agreement in raising earnings estimates is presented as a more constructive indicator for the stock.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.28
Ticker Sentiment
PGNY0.42
More News
- Pharvaris at Wells Fargo conference: oral HAE drug gains ground
- Teradyne at Goldman Sachs Communacopia + Technology Conference: ai push widens
- Oil surges back above $100 a barrel as diesel climbs to a record $5.94 per gallon
- Nano-X Imaging (NNOX) Q2 2026 Earnings Call Transcript
- Chewy (CHWY) Q2 2026 Earnings Call Transcript
- A chip stock jumps 11.7% as AI demand drives a guidance boost